SK Capital Partners | Page 14 | SK Capital Partners

SK Capital Partners / December 14, 2017

New York, December 8, 2017 – SK Capital, a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, today announced …

[Read more...] about SK Capital Announces Agreement to Acquire Fire Safety and Oil Additives Businesses from Israel Chemicals Ltd.

SK Capital Partners / November 30, 2017

Tel Aviv, Israel, November 28, 2017 – Wavelength Pharmaceuticals Ltd. (“Wavelength” or the “Company”), a former subsidiary of Perrigo Company plc that was …

[Read more...] about Wavelength Pharmaceuticals Names Iftach Seri as Chief Executive Officer and Tami Cohen as Chief Financial Officer

SK Capital Partners / November 21, 2017

New York, NY and Tel Aviv, Israel, November 21, 2017 – SK Capital, a private investment firm focused on the specialty materials, chemicals and pharmaceuticals …

[Read more...] about SK Capital Closes Acquisition of Perrigo’s API Business and Changes Name to Wavelength Pharmaceuticals

SK Capital Partners / October 3, 2017

NEW YORK, October 3, 2017 – SK Capital Partners, a private investment firm with a disciplined focus on the specialty materials, chemicals and pharmaceutical …

[Read more...] about SK Capital Expands Team with Two New Professionals

SK Capital Partners / August 17, 2017

New Investment Aimed to Support the Company’s Growth and Potential Industry Consolidation NEW YORK and BASEL, SWITZERLAND, August 17, 2017 – SK Capital …

[Read more...] about SK CAPITAL CONTINUES TO INVEST IN ARCHROMA

SK Capital Partners / August 11, 2017

New York, August 10, 2017 – SK Capital, a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, announced that it …

[Read more...] about SK Capital Announces Agreement to Acquire Perrigo Company plc’s Active Pharmaceutical Ingredients Business